Immunome stock reaches 52-week high at $25.32
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immunome Inc (IMNM)
Immunome Inc stock price live, this page displays NASDAQ IMNM stock exchange data. View the IMNM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immunome Inc real time stock price chart below.
What Is the Immunome Inc Stock Price Today?
The Immunome Inc stock price today is 25.31.
What Is the Stock Symbol for Immunome Inc?
The stock symbol for Immunome Inc is "IMNM."
What Stock Exchange Does Immunome Inc Trade On?
Immunome Inc is listed and trades on the NASDAQ stock exchange.
Is Immunome Inc a Good Stock to Buy?
Determining whether Immunome Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMNM quote. (ISIN: US45257U1088)
What Is the Immunome Inc Stock Price Today?
The Immunome Inc stock price today is 25.31.
What Is the Stock Symbol for Immunome Inc?
The stock symbol for Immunome Inc is "IMNM."
What Stock Exchange Does Immunome Inc Trade On?
Immunome Inc is listed and trades on the NASDAQ stock exchange.
Is Immunome Inc a Good Stock to Buy?
Determining whether Immunome Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMNM quote. (ISIN: US45257U1088)
NASDAQ
Currency in USD
25.31
-0.56(-2.18%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.82
26.63
52 wk Range
5.15
26.63
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.8226.63
52 wk Range
5.1526.63
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMNM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
34.50
Upside
+36.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Siegall buys Immunome (IMNM) shares worth $149k
- Investing.com
- Immunome Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Tsai Philip buys $204,899 in Immunome stock
- Investing.com
- Immunome (IMNM) CEO Siegall buys $100k in shares
- Investing.com
- Immunome stock reaches 52-week high at $25.32
- Investing.com
- Immunome Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Immunome (IMNM) CEO Siegall buys $100k in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Immunome Inc Company Profile
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company’s clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Compare IMNM to Peers and Sector
Metrics to compare | IMNM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMNMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.4x | −4.3x | −0.6x | |
PEG Ratio | −0.25 | −0.18 | 0.00 | |
Price/Book | 10.5x | 2.1x | 2.6x | |
Price / LTM Sales | 286.2x | 155.6x | 3.4x | |
Upside (Analyst Target) | 31.4% | 118.1% | 41.8% | |
Fair Value Upside | Unlock | 3.6% | 4.8% | Unlock |
Analyst Ratings
13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 34.50
(+36.31% Upside)
Earnings
Latest Release
Nov 07, 2025
EPS / Forecast
-0.65 / -0.57
Revenue / Forecast
-- / 611.11K
People Also Watch
FAQ
What Is the Immunome (IMNM) Stock Price Today?
The Immunome stock price today is 25.31
What Stock Exchange Does Immunome Trade On?
Immunome is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Immunome?
The stock symbol for Immunome is "IMNM."
What Is the Immunome Market Cap?
As of today, Immunome market cap is 2.80B.
What Is Immunome's Earnings Per Share (TTM)?
The Immunome EPS (TTM) is -2.81.
When Is the Next Immunome Earnings Date?
Immunome will release its next earnings report on Mar 18, 2026.
From a Technical Analysis Perspective, Is IMNM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Immunome Stock Split?
Immunome has split 0 times.
How Many Employees Does Immunome Have?
Immunome has 168 employees.
What is the current trading status of Immunome (IMNM)?
As of Jan 26, 2026, Immunome (IMNM) is trading at a price of 25.31, with a previous close of 25.87. The stock has fluctuated within a day range of 24.82 to 26.63, while its 52-week range spans from 5.15 to 26.63.
What Is Immunome (IMNM) Price Target According to Analysts?
The average 12-month price target for Immunome is USD34.50, with a high estimate of USD40 and a low estimate of USD26. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.31% Upside potential.
What Is the IMNM Premarket Price?
IMNM's last pre-market stock price is 25.50. The pre-market share volume is 1,200.00, and the stock has decreased by -0.37, or -1.43%.
What Is the IMNM After Hours Price?
IMNM's last after hours stock price is 25.78, the stock has decreased by -0.09, or -0.35%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.